Television viewing time and reduced life expectancy: a life table analysis Suppression of skeletal muscle lipoprotein lipase activity during physical inactivity: a molecular reason to maintain daily low - intensity activity How many steps / day are enough? (wellnessmama.com)
AMT in 2010 submitted a Marketing Authorization Application (MAA) for their lead product GLYBERA ®, a gene therapy for the treatment of lipoprotein lipase deficiency (LPLD), to the European Medicines Agency (EMA, formerly known as EMEA). (viacyte.com)
The therapy is for a rare genetic condition called lipoprotein lipase deficiency. (newscientist.com)